MAMahmoud Reza Azarpazhooh

Mahmoud Reza Azarpazhooh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mahmoud Reza Azarpazhooh has a total of 102 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Incidence, recurrence, and long-term survival of ischemic stroke subtypes: A population-based study in the Middle East

    by Hamidreza Saber, Amanda G Thrift, Moira K Kapral, Ashkan Shoamanesh, Amin Amiri, Mohammad T Farzadfard, Réza Behrouz, Mahmoud Reza Azarpazhooh

    Background: Incidence, risk factors, case fatality and survival rates of ischemic stroke subtypes are unknown in the Middle East due to the lack of community-based incidence stroke studies in this region. Aim: To characterize ischemic stroke subtypes in a Middle Eastern population. Methods: The Mashad Stroke Incidence Study is a community-based study that prospectively ascertained all cases of stroke among the 450,229 inhabitants of Mashhad, Iran between 2006 and 2007. We identified 512 cases of first-ever ischemic stroke [264 men (mean age 65.5 ± 14.4) and 248 women (mean age 64.14 ± 14.5)]. Subtypes of ischemic stroke were classified according to the TOAST criteria. Incidence rates were age standardized to the WHO and European populations. Results: The proportion of stroke subtypes was distributed as follows: 14.1% large artery disease, 15% cardioembolic, 22.5% small artery disease, 43.9% undetermined and 4.5% other. The greatest overall incidence rates were attributed to undetermined infarction (49.97/100,000) followed by small artery disease (25.54/100,000). Prevalence of hypertension, diabetes and atrial fibrillation differed among ischemic stroke subtypes. Overall, there were 268 (52.34%) deaths and 73 (14.25%) recurrent strokes at five years after incident ischemic stroke, with the greatest risk of recurrence seen in the large artery disease (35.6%) and cardioembolic (35.5%) subgroups. Survival was similar in men and women for each stroke subtype. Conclusions: We observed markedly greater incidence rates of ischemic stroke subtypes than in other countries within the Mashad Stroke Incidence Study after age standardization. Our findings should be considered when planning prevention and stroke care services in this region.


  • Nutrient patterns and their relationship to metabolic syndrome in Iranian adults

    by Sayyed Saeid Khayyatzadeh, Mohsen Moohebati, Mohsen Mazidi, Amir Avan, Maryam Tayefi, Seyed Mohammad Reza Parizadeh, Mahmoud Ebrahimi, Alireza Heidari‐Bakavoli, Mahmoud Reza Azarpazhooh, Habibollah Esmaily, et al.

    Background: The prevalence of metabolic syndrome (MetS) is increasing globally. It is associated with a significant risk of developing type 2 diabetes mellitus and cardiovascular disease.Materials and methods: The relationship between adherence to several different dietary patterns and the presence of MetS was explored in an Iranian population sample of 5764 subjects.Results: We observed that the prevalence of MetS was 13% and 18% in men and women, respectively. There were three main dietary patterns: the first pattern was characterized by protein, carbohydrate, starch, glucose, fructose, sucrose, maltose, dietary fibre, potassium, calcium, magnesium, phosphorus, iron, zinc, manganese, thiamine, riboflavin, carotene, vitamin c and lactose; second representative of fat, saturated fat, monounsaturated fat, polyunsaturated fat, cholesterol, sodium, calcium, zinc, phosphorus, iodine, vitamin D, chloride, betaine, niacin; third consisting of copper, selenium, vitamin A, riboflavin, vitamin B12. In this dietary pattern, individuals in first quintile had a higher consumption of total fat, saturated fatty acid, monounsaturated fatty acid, polyunsaturated fatty acid, cholesterol and vitamin A. In the second pattern, individuals in the fifth quintile ate less carbohydrate, dietary fibre, glucose, Fructose, potassium compared to first quintile. We found that individuals in the first quintile in pattern 3 had higher intakes of protein, zinc and calcium compared to other quintiles.Conclusions: We have found that a nutrient pattern which mostly characterized by dietary protein, carbohydrate, starch, glucose, fructose, sucrose, maltose was associated with a higher risk of MetS in both genders, while a pattern which was represent of copper, selenium, Vitamin A, riboflavin, vitamin B12 was associated with greater odds of Mets, in women.


  • Association of Age and Lipid Profiles with Measures of Renal Function in an Iranian Population

    by Maryam Mohammadi, Amir Avan, Marzieh Emamian, Abolfazl Khajavi-Rad, Malihe Aghasizadeh-Sharbaf, Maryam Tayefi, Habibollah Esmaeili, Davoud Zomorrodian, Mohsen Moohebati, Mahmoud Ebrahimi, et al.

    Purpose: We have investigated the association between markers of renal function [serum urea nitrogen, creatinine, and estimated glomerular filtration rate (eGFR)] and age and lipid profile in an Iranian population sample of 4,567 subjects. Materials/methods: Serum creatinine and urea nitrogen, together with anthropometric parameters and lipid profile were determined in all the subjects. eGFR was calculated using the modification of diet in renal disease formula. Results: Serum creatinine and urea nitrogen increased with age (p < .05), and this relationship was also more pronounced in men compared to women. Increased levels of these renal function markers were significantly associated with altered lipid profiles. Conclusion: Levels of renal function markers increased with age and were associated with altered lipid profile.


  • Obesity Paradox versus Frailty Syndrome in First-Ever Ischemic Stroke Survivors

    by Seyyed Mohammad Reza Kazemi-Bajestani, Majid Ghayour-Mobarhan, Amanda G. Thrift, Gordon A. Ferns, Mohammad Taghi Frazadfard, Naghme Mokhber, Reza Behrouz, Mahmoud Reza Azarpazhooh


  • One-year case fatality rate following stroke in the Mashhad Stroke Incidence Study: a population-based study of stroke in Iran

    by Ali Shoeibi, Maryam Salehi, Amanda G. Thrift, Moira K. Kapral, Mohammad Taghi Farzadfard, Amir Azarpazhooh, Parvaneh Layegh, Peyman Hashemi, Amin Amiri, Naghmeh Mokhber, et al.

    Background: In developing countries, there are few comprehensive studies of mortality following stroke. Aims and/or hypothesis: We aimed to determine the one-year case fatality rate following stroke and to identify factors associated with death in a population-based stroke incidence study in Iran. Methods: Six hundred eighty-four patients who had suffered a stroke between November 21, 2006, and November 20, 2007, and were recruited to the Mashhad Stroke Incidence Study were followed up at one-year. Most patients were seen in an outpatient visit. When patients had died, a verbal autopsy was conducted by telephone with the next of kin. Results: A total of 226 (34.3%) patients died during the first year following stroke. The cumulative one-year case fatality rate was 30.6% following ischemic stroke and 53.0% following hemorrhagic stroke (55.8% after intracerebral hemorrhage and 35.7% after subarachnoid hemorrhage). The majority of these deaths occurred in the first 28 days after stroke (17.7% with ischemic and 43.0% with hemorrhagic stroke). Factors associated with greater mortality at one-year (excluding those who died during the first week) were hemorrhagic stroke [hazard ratio (HR) 3.99; 95% confidence interval 1.90-8.37], age (HR 1.05; 95% confidence interval 1.03-1.08), previous transient ischemic attack (HR 2.45; 95% confidence interval 1.00-5.99), and National Institutes of Health Stroke Scale on admission (HR 1.14; 95% confidence interval 1.10-1.17). Conclusion: Despite the younger age of stroke occurrence in Iran, the one-year case fatality rate following stroke is similar to that reported in developed countries.


  • Therapeutic effect of Avonex, Rebif and Betaferon on quality of life in multiple sclerosis

    by Naghmeh Mokhber, Amir Azarpazhooh, Elias Orouji, Bita Khorram, Morteza Modares Gharavi, Sorayya Kakhi, Hoda Khallaghi, Mahmoud Reza Azarpazhooh

    Aims: The aim of this study was to evaluate the effect of various disease‐modifying therapies (DMT) on quality of life in multiple sclerosis (MS).Methods: This was a three‐arm parallel study with balanced randomization in which 90 newly diagnosed, definite MS subjects referred to Ghaem Medical Center, Mashhad, Iran were enrolled between 2006 and 2009. Patients were randomly allocated into three DMT groups: Avonex, Rebif and Betaferon. Health‐related quality of life was assessed in MS patients at baseline and 12 months after treatment with DMT using the MS Quality of Life‐54 questionnaire.Results: Both mental and physical health scores improved within all three treatment groups after 12 months of treatment; however, this increase was only significant in the mental health composite in the Betaferon group (P = 0.024). Betaferon had the highest mental health score change (14.04) while this change was 7.26 for Avonex (P = 0.031) and 5.08 for Rebif (P = 0.017). A physical health composite score comparison among the three treatment groups revealed no significant results.Conclusions: With a positive impact of DMT on mental and physical dimensions of QOL in MS patients, initiation of treatment soon after diagnosis is recommended. In MS patients with more mental issues and fewer physical disabilities, Betaferon might be considered as a better choice of treatment.


  • Mashhad stroke and heart atherosclerotic disorder (MASHAD) study: design, baseline characteristics and 10-year cardiovascular risk estimation

    by Majid Ghayour-Mobarhan, Mohsen Moohebati, Habibollah Esmaily, Mahmoud Ebrahimi, Seyed Mohammad Reza Parizadeh, Ali Reza Heidari-Bakavoli, Mohammad Safarian, Naghmeh Mokhber, Mohsen Nematy, Hamidreza Saber, et al.

    The Mashhad stroke and heart atherosclerotic disorder (MASHAD) study is a 10-year cohort study that aims to evaluate the impact of various genetic, environmental, nutritional and psychosocial risk factors on the incidence of cardiovascular events among an urban population in eastern Iran. The MASHAD study comprises a cohort of 9704 individuals aged 35–65 years using a stratified cluster random sampling design. This cohort will be followed up until 2020, with follow-up examinations being undertaken every 3 years. Ten-year cardiovascular disease (CVD) risk estimation was determined using NCEP ATP III criteria. Overall, 88.4 % of women and 79.2 % of men (P < 0.001) had at least one lipid abnormality. The 10-year risk for CVD of 20 % were observed to be 86.6, 11 and 2.5 %, respectively. Predicted risk of CVD > 10 % using the Framingham algorithm was considerably higher in men compared to women. Overall, 9.5 % [95 % confidence interval (CI) 8.9–10.1 %] of our subjects had prevalent CAD. The prevalence of CVD risk factors within our population is high compared to Western countries, indicating the necessity for interventional risk modifications.


  • Gaps and Hurdles Deter against Following Stroke Guidelines for Thrombolytic Therapy in Iran: Exploring the Problem

    by Karim Nikkhah, Abolfazl Avan, Ali Shoeibi, Amir Azarpazhooh, Kavian Ghandehari, Christian Foerch, Gustavo Saposnik, Payam Sasannejad, Veda Vakili, Parvaneh Layegh, et al.


  • Open Access

    Incidence of first ever stroke during Hajj ceremony

    by Mahmoud Reza Azarpazhooh, Reza Bavarsad Shahripour, Moira K Kapral, Naghmeh Mokhber, Ali Shoeibi, Mohammad Taghi Farzadfard, Mohammad Reza Rafati, Amanda G Thrift, Negar Morovatdar, Seyed Aidin Sajedi, et al.

    The Hajj Ceremony, the largest annual gathering in the world, is the most important life event for any Muslim. This study was designed to evaluate the incidence of stroke among Iranian pilgrims during the Hajj ceremony.


  • Clinical features of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in northeast Iran

    by Ali Shoeibi, Houshang Rafatpanah, Amir Azarpazhooh, Naghme Mokhber, Mohammad Reza Hedayati-Moghaddam, Amin Amiri, Peyman Hashemi, Mohsen Foroghipour, Reza Farid Hoseini, Ali Bazarbachi, et al.

    This study aimed to introduce clinical manifestations of patients in northeast Iran with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and describe the epidemiological features, as well as risk factors for HTLV-1 infection. This is a cross-sectional study of HTLV-1 infected cases and HAM/TSP patients referred by outpatient neurology clinics as well as Mashhad Blood Transfusion Center from 2005 to 2010. The study comprises 513 cases, including 358 healthy carriers (HCs) and 145 HAM/TSP patients. The majority of carriers were male (73.5 %), whereas 67.6 % of HAM/TSP sufferers were female (P < 0.001). The mean age of HAM/TSP patients and HCs was 45.9 ± 13.6 and 39.5 ± 11.58 years, respectively (P < 0.001). The history of transfusion, surgery, hospitalization and cupping was observed in a significant greater number of HAM/TSP patients than the HCs (P < 0.001, P < 0.001, P < 0.001 and P = 0.029, respectively). Gait disturbance was the most common complaint in HAM/TSP patients (72.4 %). This research develops an HTLV-1 data registry in an endemic area such as Mashhad which can serve useful purposes, including evaluation of clinical and laboratory characteristics of HAM/TSP patients and epidemiological data of HTLV-1-infected cases.